{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:23:15Z","timestamp":1790644995150,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>\n                    Antenatal magnesium sulfate (MgSO\n                    <jats:sub>4<\/jats:sub>\n                    ) may provide neuroprotective benefits in preterm infants. This study examined the impact of antenatal MgSO\n                    <jats:sub>4<\/jats:sub>\n                    on the neurodevelopmental outcomes of very low birth weight (VLBW) preterm infants at the corrected age of 2 years. This retrospective follow-up study included preterm infants with a birth weight\u2005\u2264\u20051500\u2009g and gestational age\u2005\u2264\u200536 weeks who participated in a follow-up program. Antenatal MgSO\n                    <jats:sub>4<\/jats:sub>\n                    was administered to treat maternal preeclampsia or for neuroprotection or tocolysis. Neurodevelopmental outcomes, including cerebral palsy (CP), neurodevelopmental impairment (NDI), and audiologic and visual assessments, were evaluated at a corrected age of 2 years. Infants exposed to MgSO\n                    <jats:sub>4<\/jats:sub>\n                    were compared with unexposed controls. Among 328 VLBW infants (2007\u20132015), 133 were exposed to MgSO\n                    <jats:sub>4<\/jats:sub>\n                    , and 195 were not. Follow-up data were available for 93.3% of the infants. CP occurred in 6.0% of MgSO\n                    <jats:sub>4<\/jats:sub>\n                    exposed infants versus 13.8% of controls (odds ratio: 0.39; 95% confidence interval: 0.18\u20130.91;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03). NDI was observed in 19.5% of exposed infants compared with 31.3% of controls (odds ratio: 0.53; 95% confidence interval: 0.32\u20130.90;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02). Multivariate logistic regression showed that low parental educational level (&lt;college), birth weight (&lt;1000\u2009g), and periventricular leukomalacia were significantly associated with an increased rate of CP. Similarly, independent factors such as preeclampsia, low socioeconomic status, birth weight\u2005&lt;\u20051000\u2009g, male sex, and periventricular leukomalacia were significantly associated with an increased risk of NDI. Antenatal MgSO\n                    <jats:sub>4<\/jats:sub>\n                    administration in pregnant women may have neuroprotective effects in VLBW preterm infants, reducing the risk of CP and NDI at the corrected age of 2 years.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043385","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:20Z","timestamp":1753156880000},"page":"e43385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Neuroprotective effects of antenatal magnesium sulfate on neurodevelopmental outcomes in very low birth weight preterm infants: A 2-year follow-up study"],"prefix":"10.1097","volume":"104","author":[{"given":"Wai-Tim","family":"Jim","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei City, Taiwan"},{"name":"MacKay Medical College, New Taipei City, Taiwan"},{"name":"MacKay Junior College of Medicine, Nursing and Management College, Taipei City, Taiwan"},{"name":"National Taipei University of Nursing and Health Sciences, Taipei City, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hsing","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei City, Taiwan"},{"name":"MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yang","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei City, Taiwan"},{"name":"MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chih","family":"Peng","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei City, Taiwan"},{"name":"MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyong-Hsin","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000260136","article-title":"Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998\u20132003.","volume":"97","author":"Mercier","year":"2010","journal-title":"Neonatology"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood.","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa041367","article-title":"Neurologic and developmental disability at six years of age after extremely preterm birth.","volume":"352","author":"Marlow","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpeds.2022.01.042","article-title":"High-risk neighborhoods and neurodevelopmental outcomes in infants born preterm.","volume":"245","author":"Nwanne","year":"2022","journal-title":"J Pediatr"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3345\/cep.2022.00822","article-title":"Neurodevelopmental outcomes of preterm infants.","volume":"66","author":"Song","year":"2023","journal-title":"Clin Exp Pediatr"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"e0192574","DOI":"10.1371\/journal.pone.0192574","article-title":"Post-discharge body weight and neurodevelopmental outcomes among very low birth weight infants in Taiwan: a nationwide cohort study.","volume":"13","author":"Hsu","year":"2018","journal-title":"PLoS One"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1056\/NEJM199401203300308","article-title":"Cerebral palsy.","volume":"330","author":"Kuban","year":"1994","journal-title":"N Engl J Med"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1542\/peds.2010-1656","article-title":"Racial, ethnic, and socioeconomic disparities in the prevalence of cerebral palsy.","volume":"127","author":"Wu","year":"2011","journal-title":"Pediatrics"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/NDT.S235165","article-title":"Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options.","volume":"16","author":"Sadowska","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-1231","article-title":"Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening.","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9378(77)90808-0","article-title":"A comparison of magnesium sulfate and alcohol for the prevention of premature labor.","volume":"129","author":"Steer","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","article-title":"Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(90)90569-U","article-title":"Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats.","volume":"109","author":"McDonald","year":"1990","journal-title":"Neurosci Lett"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","article-title":"Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?","volume":"95","author":"Nelson","year":"1995","journal-title":"Pediatrics"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.","volume":"359","author":"Rouse","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-20250722","first-page":"CD004661","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.","volume":"5","author":"Shepherd","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2002.123544","article-title":"Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.","volume":"186","author":"Mittendorf","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MPG.0000000000003912","article-title":"Antenatal neuroprotective magnesium sulfate in very preterm infants and its association with feeding intolerance.","volume":"77","author":"Ozer Bekmez","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ANC.0b013e31821ba28e","article-title":"Feeding intolerance: a concept analysis.","volume":"11","author":"Moore","year":"2011","journal-title":"Adv Neonatal Care"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/s41598-023-42124-y","article-title":"Bridging geographical disparities across 368 townships with healthcare system and socioeconomic factors in Taiwan.","volume":"13","author":"Hsieh","year":"2023","journal-title":"Sci Rep"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-8749.2000.tb00695.x","article-title":"Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).","volume":"42","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.","volume":"92","author":"Papile","year":"1978","journal-title":"J Pediatr"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"101109","DOI":"10.1016\/j.siny.2020.101109","article-title":"International comparisons of neurodevelopmental outcomes in infants born very preterm.","volume":"25","author":"Torchin","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJMcibr0902052","article-title":"Memory and the NMDA receptors.","volume":"361","author":"Li","year":"2009","journal-title":"N Engl J Med"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.STR.0000259628.94421.09","article-title":"Magnesium for treatment of acute lacunar stroke syndromes: further analysis of the IMAGES trial.","volume":"38","author":"Aslanyan","year":"2007","journal-title":"Stroke"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.placenta.2022.07.011","article-title":"Magnesium sulphate neuroprotection mechanism is placental mediated by inhibition of inflammation, apoptosis and oxidative stress.","volume":"127","author":"Khatib","year":"2022","journal-title":"Placenta"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jogc.2018.09.018","article-title":"No. 376-magnesium sulphate for fetal neuroprotection.","volume":"41","author":"Magee","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 2","key":"R30-20250722","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijgo.13856","article-title":"Abstracts of the XXIII FIGO world congress of gynecology & obstetrics.","volume":"155","author":"Shennan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"e2451","DOI":"10.1097\/MD.0000000000002451","article-title":"Effects and safety of magnesium sulfate on neuroprotection: a meta-analysis based on PRISMA guidelines.","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R32-20250722","first-page":"CD011200","article-title":"Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.","volume":"2015","author":"McNamara","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.ajog.2014.07.023","article-title":"Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.","volume":"212","author":"De Jesus","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1055\/s-0036-1581059","article-title":"Antenatal magnesium sulfate, necrotizing enterocolitis, and death among neonates < 28 weeks gestation.","volume":"6","author":"Kamyar","year":"2016","journal-title":"AJP Rep"},{"key":"R35-20250722","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1136\/archdischild-2013-305884","article-title":"Intrapartum magnesium sulfate and need for intensive delivery room resuscitation.","volume":"100","author":"Weisz","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R36-20250722","doi-asserted-by":"crossref","first-page":"e1002988","DOI":"10.1371\/journal.pmed.1002988","article-title":"Antenatal magnesium sulphate and adverse neonatal outcomes: a systematic review and meta-analysis.","volume":"16","author":"Shepherd","year":"2019","journal-title":"PLoS Med"},{"key":"R37-20250722","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.semperi.2016.05.011","article-title":"Changing definitions of long-term follow-up: Should \u201clong term\u201d be even longer?","volume":"40","author":"Hintz","year":"2016","journal-title":"Semin Perinatol"},{"key":"R38-20250722","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/dmcn.12865","article-title":"Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003.","volume":"58","author":"Sellier","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"R39-20250722","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/jcm13123480","article-title":"The prevalence and risk analysis of cerebral palsy and other neuro-psychological comorbidities in children with low birth weight in Taiwan: a nationwide population-based cohort study.","volume":"13","author":"Fan","year":"2024","journal-title":"J Clin Med"},{"key":"R40-20250722","doi-asserted-by":"crossref","first-page":"850877","DOI":"10.3389\/fneur.2022.850877","article-title":"Identification of risk factors in pre-term infants with abnormal general movements.","volume":"13","author":"Domagalska-Szopa","year":"2022","journal-title":"Front Neurol"},{"key":"R41-20250722","doi-asserted-by":"crossref","first-page":"e0255352","DOI":"10.1371\/journal.pone.0255352","article-title":"ELBW and ELGAN outcomes in developing nations-systematic review and meta-analysis.","volume":"16","author":"Ramaswamy","year":"2021","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:24Z","timestamp":1753156884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":41,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043385","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}